These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 2260089)
21. Effect of interleukins and anti-CD3 monoclonal antibody on the proliferation of thymocytes from irradiated mice. Daculsi R; Legrand E; Vaillier D; Duplan JF; Guillemain B Thymus; 1991 Mar; 17(2):97-113. PubMed ID: 1827549 [TBL] [Abstract][Full Text] [Related]
22. Trypanosoma cruzi-induced suppression of IL-2 production. I. Evidence for the presence of IL-2-producing cells. Tarleton RL J Immunol; 1988 Apr; 140(8):2763-8. PubMed ID: 2965729 [TBL] [Abstract][Full Text] [Related]
23. The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens. Baroja ML; Lorre K; Van Vaeck F; Ceuppens JL Cell Immunol; 1989 Apr; 120(1):205-17. PubMed ID: 2539266 [TBL] [Abstract][Full Text] [Related]
24. Interleukin-1 synthesis and activity in aged mice. Bruley-Rosset M; Vergnon I Mech Ageing Dev; 1984 Mar; 24(3):247-64. PubMed ID: 6232433 [TBL] [Abstract][Full Text] [Related]
25. The pharmacologic regulation of interleukin-1 production: the role of prostaglandins. Otterness IG; Bliven ML; Eskra JD; Reinke M; Hanson DC Cell Immunol; 1988 Jul; 114(2):385-97. PubMed ID: 2968844 [TBL] [Abstract][Full Text] [Related]
26. T cell activation through TCR/-CD3 complex. IL-2 production of T cell clones stimulated with anti-CD3 without cross-linkage. Tamura T; Nariuchi H J Immunol; 1992 Apr; 148(8):2370-7. PubMed ID: 1532813 [TBL] [Abstract][Full Text] [Related]
27. Interleukin 4 suppresses interleukin 2 and interferon gamma production by naive T cells stimulated by accessory cell-dependent receptor engagement. Tanaka T; Hu-Li J; Seder RA; Fazekas de St Groth B; Paul WE Proc Natl Acad Sci U S A; 1993 Jul; 90(13):5914-8. PubMed ID: 8100998 [TBL] [Abstract][Full Text] [Related]
28. Mechanism of action of the new immunomodulator LS2616 on T cell responses. Larsson EL; Joki A; Stålhandske T Int J Immunopharmacol; 1987; 9(4):425-31. PubMed ID: 2957330 [TBL] [Abstract][Full Text] [Related]
29. Interleukin-1-independent activation of human T lymphocytes stimulated by anti-CD3 and a Hodgkin's disease cell line with accessory cell activity. Ellis TM; McMannis JD; Chua AO; Gubler U; Fisher RI Cell Immunol; 1988 Oct; 116(2):352-66. PubMed ID: 2972387 [TBL] [Abstract][Full Text] [Related]
30. Enhanced interleukin production after long-term administration of erythromycin stearate. Kita E; Sawaki M; Nishikawa F; Mikasa K; Yagyu Y; Takeuchi S; Yasui K; Narita N; Kashiba S Pharmacology; 1990; 41(4):177-83. PubMed ID: 2080228 [TBL] [Abstract][Full Text] [Related]
31. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Kennedy MK; Picha KS; Fanslow WC; Grabstein KH; Alderson MR; Clifford KN; Chin WA; Mohler KM Eur J Immunol; 1996 Feb; 26(2):370-8. PubMed ID: 8617306 [TBL] [Abstract][Full Text] [Related]
32. Tumor modulation of autoreactivity: decreased macrophage and autoreactive T cell interactions. Yurochko AD; Burger CJ; Elgert KD Cell Immunol; 1990 Apr; 127(1):105-19. PubMed ID: 2138515 [TBL] [Abstract][Full Text] [Related]
33. Age differences in eicosanoid production of mouse splenocytes: effects on mitogen-induced T-cell proliferation. Hayek MG; Meydani SN; Meydani M; Blumberg JB J Gerontol; 1994 Sep; 49(5):B197-207. PubMed ID: 8056932 [TBL] [Abstract][Full Text] [Related]
34. Induction of interleukin-3 by interleukin-1 in the absence of other exogenous stimuli. Cavaillon JM; Vidard L; Boudaly S; Fitting C; Cohen L; Seman M; David B Cell Immunol; 1990 Aug; 129(1):176-88. PubMed ID: 2364439 [TBL] [Abstract][Full Text] [Related]
35. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2. Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366 [TBL] [Abstract][Full Text] [Related]
36. Cell surface glycoproteins involved in the stimulation of interleukin 1-dependent interleukin 2 production by a subline of EL4 thymoma cells. I. Functional characterization by monoclonal antibodies. MacDonald HR; Lees RK; Bron C J Immunol; 1985 Dec; 135(6):3944-50. PubMed ID: 2415592 [TBL] [Abstract][Full Text] [Related]
37. Immunosine (7-thia-8-oxoguanosine) acts as a cofactor for proliferation of T cells. Colić M; Jandrić D; Gasić S; Vucević D; Popović P; Medić-Mijacević L; Rakić L Fundam Clin Pharmacol; 2000; 14(3):209-17. PubMed ID: 15602797 [TBL] [Abstract][Full Text] [Related]
38. Production of T cell differentiation factor in syngeneic lymphocyte macrophage culture for cytotoxic T lymphocyte generation. Ting CC; Hargrove ME; Loh NN J Immunol; 1986 Mar; 136(5):1726-33. PubMed ID: 2936809 [TBL] [Abstract][Full Text] [Related]
39. Radiosensitivity and responsiveness to recombinant interleukin-2 of effector cells of graft vs. host disease and mixed lymphocyte reaction in mice. Stark J; Weiss L; Slavin S Isr J Med Sci; 1992 Nov; 28(11):767-72. PubMed ID: 1468887 [TBL] [Abstract][Full Text] [Related]
40. Immunotoxic effects of prolonged dietary exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Badesha JS; Maliji G; Flaks B Eur J Pharmacol; 1995 Dec; 293(4):429-37. PubMed ID: 8748696 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]